http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2708824-C1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6ac921dff7d1e7fa0619a3f776955c67
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F9-008
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F9-007
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F9-00821
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-008
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-007
filingDate 2018-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2019-12-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_16390f503093bc7c5ed3d2f66bc281e4
publicationDate 2019-12-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2708824-C1
titleOfInvention Method of endovitreal treatment of rhegmatogenous retinal detachment
abstract FIELD: medicine.SUBSTANCE: invention relates to medicine, specifically to ophthalmology. For surgical treatment of rhegmatogenous retinal detachment combined with posterior vitreous detachment, three punctures are made in flat part of ciliary body, subtotal vitrectomy, substitution of physiological solution and endolaser coagulation of retina around rupture. During the vitrectomy, the periphery and the retinal rupture area are scrapped with sclerocompression. That is followed by physiological solution replacement with air to the level of rupture and aspiration of the subretinal liquid in the air. Remaining physiologic solution is removed from vitreal cavity, endolaser coagulation of retina around rupture is performed with sclerocompression. Operation is completed by gas-air tamponade and removal of ports.EFFECT: method enables intraoperative complete adhesion of eyeballs, excludes the need for introduction into the vitreous cavity of PFOC, and therefore reduces injuries by eliminating all possible complications associated with its use, time of surgical intervention.1 cl, 2 ex
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2720528-C1
priorityDate 2018-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2675463-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2325884-C2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2548814-C2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2203001-C2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2578866-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2394533-C1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448670727
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419526573
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID74483
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5234

Total number of triples: 26.